Legacy offers at-home sperm testing kits plus laboratory sperm analysis, DNA fragmentation testing, post-thaw verification, cryopreservation and virtual medical support. The company provides personalized lifestyle recommendations and sells male fertility supplements developed with urology experts. Legacy reports strong historical revenue growth—revenue increased seven-fold in 2020 and quadrupled in 2021—and currently tests and freezes more sperm than any other fertility clinic. Its services are covered for roughly 8 million lives through fertility benefits partnerships and an additional 12 million lives through insurance contracts in California, New York, and New Jersey with insurers including Aetna, Cigna, and UnitedHealthcare. With the new funding, Legacy plans to double headcount, expand offerings beyond sperm testing and freezing, and launch Legacy Labs to provide same-day, at-home lab services for urgent needs like pre-surgery or cancer treatment. The company emphasizes accessibility for military and transgender communities through targeted programs and partnerships. Legacy provides consumers a discrete mail-order kit that preserves a semen sample for up to 48 hours and returns to one of the company's locations for lab analysis. Lab technicians analyze samples and upload a digital fertility report within 24 hours detailing volume, count, concentration, motility and morphology alongside personalized lifestyle advice. Based on the package selected, customers can opt to have samples frozen by a partner cryogenic storage center; the company emphasizes security measures including physical surveillance, asset diversification and HIPAA- and GDPR-compliant data practices. The company also recently launched a B2B offering aimed at employers to extend male fertility benefits. CEO Khaled Kteily confirmed the company raised new funding and teased several upcoming products and services, including a "sperm score" developed by the company's Harvard-based researchers. Legacy originated from the Harvard Innovation Labs alumni incubator program. Legacy is a Harvard Innovation Labs startup focused on at-home male fertility testing, improvement, and cryogenic sperm storage. The company ships kits to clients' homes, sends samples to partner clinics for clinical-level analysis, and returns a full fertility report within 24 hours that analyzes volume, count, concentration, motility, and morphology. Clients can also opt to freeze their deposit at world-class cryogenic storage facilities. Legacy has built a recommendation engine that analyzes over 50 data points per client to provide personalized assessments and lifestyle recommendations. The company emphasizes privacy—assigning unique CLIENTIDs, using end-to-end encryption, and dividing deposits across geographic locations to support HIPAA and GDPR compliance. Legacy recently raised $1.5 million led by Bain Capital Ventures to expand its suite of male fertility offerings. Legacy provides an at-home sperm collection system that ships samples to clinics for fertility analysis and cryogenic storage. Clients receive a full fertility analysis and personalized recommendations driven by machine-learning technology. The company emphasizes privacy, security and multi-site storage, keeping deposits in multiple tanks and locations. Legacy offers tiered packages (Bronze, Gold, Platinum), with Bronze at $1,000 and Platinum at $10,000, which stores up to six samples indefinitely. Founder Khaled Kteily started the company after helping a friend facing cancer and positions Legacy as a “Swiss Bank” for sperm storage. The company has raised $250,000 and is profitable.

Total raised

$30M

Funding rounds

4

Latest round

Series B

Latest activity

May 2022